Analyst Price Target is $20.00
▲ +185.31% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Nyxoah in the last 3 months. The average price target is $20.00, with a high forecast of $30.00 and a low forecast of $13.00. The average price target represents a 185.31% upside from the last price of $7.01.
Current Consensus is
Buy
The current consensus among 4 investment analysts is to buy stock in Nyxoah.
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Read More